Clinical trials recruiting for Lung Cancer Non-Small Cell Cancer (NSCLC)
3
Recruiting trials
1
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 1 |
| Chemoradiotherapy | 1 |
| EGFR-TKIs Combined with PD-1 Monoclonal Antibody | 1 |
| Immunotherapy | 1 |
| Ivonescimab | 1 |
| Pemetrexed | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 1 |
Top cities
Self-screener
Recruiting trials
- EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC
- Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
- Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
Related conditions
Trials recruiting for Lung Cancer Non-Small Cell Cancer (NSCLC) often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Non-small cell lung cancer 507Lung Cancer Non Small Cell 24EGFR Activating Mutation 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Cancer Non-Small Cell Cancer (NSCLC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.